Stockreport

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio [Yahoo! Finance]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF NovoBody™ Duo molecules offer multi-specific binding capabilities for advanced research and diagnostics Collaboration aligns with Bio-Techne's strategic growth pillar [Read more]